We are live on ! Find out more
IGC icon

IGC Pharma
IGC

6 hedge funds and large institutions have $26K invested in IGC Pharma in 2015 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more capital invested

Capital invested by funds: $10K → $26K (+$16K)

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

20% more funds holding

Funds holding: 5 → 6 (+1)

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
+$11.1K
2
UBS Group
UBS Group
Switzerland
+$5.1K
3
Citadel Advisors
Citadel Advisors
Florida
+$1.97K
4
Bank of America
Bank of America
North Carolina
+$880

Top Sellers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
VKH
1
Virtu KCG Holdings
New York
$10K +$11.1K +25,204 New
Citadel Advisors
2
Citadel Advisors
Florida
$9K +$1.97K +4,464 +24%
UBS Group
3
UBS Group
Switzerland
$5K +$5.1K +11,576 New
LTFS
4
Ladenburg Thalmann Financial Services
Florida
$1K – – –
Bank of America
5
Bank of America
North Carolina
$1K +$880 +2,000 New
AllianceBernstein
6
AllianceBernstein
Tennessee
– -$1K -3,000 Closed

IGC Hedge Fund Activity: Q2 2015 in Review

6 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in IGC Pharma (IGC) for Q2 2015, worth a combined $26K — up 160% from $10K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new IGC positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $11.1K. The largest seller was AllianceBernstein, exiting entirely with an estimated $1K sold.

  • 6 institutional investors held IGC Pharma (IGC) as of Q2 2015, up from 5 in Q1 2015.
  • Funds reported $26K of IGC Pharma stock for Q2 2015, up 160% quarter-over-quarter.
  • 3 funds opened new IGC Pharma positions in Q2 2015 and 2 closed out, a net change of +1 holder.
  • The largest IGC Pharma buyer in Q2 2015 was Virtu KCG Holdings, an estimated $11.1K added.
  • The largest IGC Pharma seller in Q2 2015 was AllianceBernstein, an estimated $1K sold.

Based on aggregated 13F filings for Q2 2015.